Trial intelligence / Profile preview

Valsartan Monotherapy vs Combination in Hypertension

NCT00280540Phase 4Completed

Sponsor
Novartis
Start
Dec 2005
Primary completion
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of valsartan in hypertension (HTN), sponsored by Novartis. Started Dec 2005; status: completed.

02

Drugs

valsartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00280540.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00280540.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call